CD5L and neoplasm: Of these 21, we focused on 5 proteins (YWHAE, PFN1, LCP1, IGHM, CD5L) that were enriched in external CNSL cohorts,26,27,33 thereby supporting their utility as CNSL-enriched tumor burden biomarkers (Figure 4E and Supplementary Figure S4C).